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ABSTRACT
Pituitary macroadenomas are benign tumors in the pituitary gland 
measuring more than 1 cm in diameter. Pituitary macroadenomas 
account for 8 to 10% of all intracranial tumors and occur primarily 
in the anterior pituitary lobe and rarely in the posterior lobe. Most 
pituitary macroadenomas are non-functioning tumors, which show 
clinical symptoms due to tumor pressure and do not increase hormonal 
activity. In this case, a 40 y.o. woman was diagnosed with a pituitary 
macroadenoma after showing clinical symptoms of a functioning tumor, 
namely acromegaly, prognathism, and large, beefy hands and feet, for the 
past 4 years. Complaints were accompanied by amenorrhea, intermittent 
cephalgia, and hemianopsia in the right eye. Blood laboratory tests revealed 
increased levels of prolactin and growth hormone, while the results of 
computed tomography (CT) scans and magnetic resonance imaging (MRI) 
of the head indicate the presence of a pituitary macroadenoma. Endoscopic 
transsphenoidal surgery, a minimally invasive procedure, was performed 
with minimal complications.
ABSTRAK
Makroadenoma hipofise merupakan tumor jinak pada kelenjar hipofise, 
yang berukuran lebih dari 1 cm. Kejadian adenoma hipofise berkisar 
8 – 10% dari seluruh tumor intracranial dan terutama terjadi pada 
lobus anterior hipofise dan jarang pada lobus posterior. Mayoritas 
kasus makroadenoma hipofise merupakan tumor non-fungsional, 
yang menimbulkan gejala klinis karena pendesakan tumor dan tidak 
meningkatkan aktivitas hormonal, seperti hal-nya pada tumor fungsional. 
Dilaporkan kasus seorang wanita usia 40 tahun, dengan makroadenoma 
hipofise yang menimbulkan gejala klinis tumor fungsional, yaitu 
akromegali sejak 4 tahun yang lalu; ditandai dengan adanya prognathism 
dan large beefy hands and feet. Keluhan disertai dengan amenorrhea, 
nyeri kepala intermiten dan hemianopsia mata kanan. Dari pemeriksaan 
laboratorium darah, ditemukan peningkatan kadar hormon prolactin 
dan pertumbuhan. Hasil computed tomography (CT scan) dan magnetic 
resonance imaging (MRI) kepala menunjukkan adanya makroadenoma 
hipofise. Endoscopic transsphenoidal (MRI) kepala menunjukkan adanya 
makroadenoma hipofise. Kemudian dilakukan operasi endoskopi 
endonasal transsphenoidal pada pasien ini, dengan komplikasi minimal.
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INTRODUCTION
Pituitary adenomas are benign 
tumors originating from cells in the 
pituitary gland that ultimately fill 
sellar and suprasellar spaces.1-3 Such 
tumors are categorized as functioning 
if they increase the pituitary hormone 
production and vice versa.1,2 Depending 
upon their size, pituitary adenomas are 
classified as either microadenoma (i.e., <1 
cm in diameter) or macroadenoma (i.e., 
>1 cm in diameter).4 Accounting for 8 to 
10% of all intracranial tumors, pituitary 
adenomas have a peak distribution at 
35-45 years of age in a nearly equal ratio 
between the sexes. Pituitary adenomas 
occur primarily in the anterior pituitary 
lobe and rarely in the posterior lobe.4,5
Schloffer first successfully removed 
the pituitary gland by following a 
transsphenoidal approach in 1906, In 
1912, Harvey Cushing modified the 
sublabial transsphenoidal approach 
by using a modified form of the 
Schloffer method in a patient with 
acromegaly.4,6 Decades later, endoscopy-
guided transsphenoidal surgery was 
standardized by Jho and Carrauin in 
1997, and 2002, Cappabianca et al.6 
introduced a method of enhancing the 
illumination and visualization of the 
tumor.7 At present, innovative sellar and 
parasellar surgical procedures are being 
implemented after endoscopy.4,6
We reported in this study a rare case 
of functioning pituitary macroadenoma 
and successful endoscopic 
transsphenoidal tumor endoscopy as a 
minimally invasive approach.
CASE
A 40-year-old woman presented 
with the chief complaint of having 
enlarged fingers and toes for the past 4 
years, which she recognized due to the 
seemingly gradual narrowing of her 
shoes. The complaint was accompanied 
by intermittent headaches, also for the 
past 4 years but with increased frequency 
during the previous 2 months. The patient 
also reported increasingly blurred vision 
toward the center of her right eye and 
enlarged upper eyelids, despite no pain 
or redness in either eye. Her forehead 
and jaw had widened and begun to 
protrude. During the past 4 years, the 
patient had also never menstruated, 
whereas her previous menstrual pattern 
was once monthly for approximately 6 
days each time. The patient also denied 
experiencing any decreased appetite or 
weight loss, weakness or fatigue, heart 
palpitations, or milky discharge from the 
nipples.
The patient married and with a 
daughter. There was no history of 
abortion, trauma, contraceptives use, 
recent drugs use, hypertension, diabetes 
mellitus, heart or kidney disorders, or 
surgery. She also denied any history 
of congenital disease, malignancy, or 
conditions resembling her current 
complaint.
The patient’s physical examination 
revealed vital signs and nutritional 
status within the normal limits and no 
abnormalities in the neck, thorax, or 
abdomen. However, compared with 
previous 5 years image, the forehead 
was protruding, the nose and lips had 
widened, and mandibular prognathism. 
Interdental dilation and malocclusion 
could be observed. All fingers and toes 
on both hands and feet also became 
enlarged and beefy, even without edema. 
The clinical presentation of the patients 
is depicted in FIGURE 1.
An endocrinological examination 
in the laboratory revealed an increase 
in prolactin levels as much as 48.3 ng /
mL (normal value: 2.8–29.2 ng/mL) 
and growth hormone as much as 107.0 
ng/mL (normal value: <8 ng/mL). An 
ophthalmologist also performed a 
fundoscopy that revealed optic atrophy 
in the right eye (i.e., pallor of the optic 
nerve head), while a perimetric test 
demonstrated nasal hemianopsia in 
the right eye and nasal peripheral 
hemianopsia in the left eye (FIGURE 2).
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FIGURE 1. Physical examination: A) Facial shape 5 years before 
being diagnosed with pituitary macroadenoma and 
B) when diagnosed with pituitary macroadenoma, 
along with large, beefy C) hands and D) feet.
FIGURE 2. Funduscopic examination: A) Optic atrophy in the 
right eye (black arrow), B) normal funduscopy of 
the left eye, C) nasal hemianopsia in a perimetric 
image of the right eye, and D) defect of the nasal 
peripheral visual field inthe left eye.
year 2011 year 2016
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FIGURE 3. ACT scan of heads hows a slight hyperdense mass on the sella turcica 
in the (A) axial, (B) coronal, and (C) sagittal planes (yellow arrow), 
with a lobulated size of 33.4 × 20.7 × 28.7 mm, which suggests a 
pituitary macroadenoma. An MRI of the head in the (D) axial, (E) 
coronal, and (F) sagittal planes (blue arrow) shows a contrasting 
suprasellar round, lobulated, well-defined isointense mass in the 
pituitary area, with mostly regular edges and measuring 33 × 21 × 
34 mm, which also suggests a pituitary macroadenoma.
A computed tomography (CT) scan 
without contrast and magnetic resonance 
imaging (MRI) of the head shows a 
pituitary macroadenoma 33.4 mm 
long, 20.7 mm wide, and 28.7 mm deep 
extending upward and out of the sella 
turcica and, in the process, stretching 
the optic chiasm and optic nerves. The 
tumor distends the thin bone at the base 
of the sell  turcica into the sphenoid 
sinus (FIGURE 3).
Based on the patient’s history, 
physical examination, and supporting 
examinations, the patient was 
diagnosed with a functioning pituitary 
macroadenoma, then the patient 
begins to be prepared for endoscopic 
transsphenoidal surgery to remove the 
tumor.
We performed endoscopic 
transsphenoidal surgery under general 
anesthesia. The patient was placed in the 
supine position on the operating table, 
with the back elevated at a 30° angle 
and the head tilted back at a 20° angle, 
rotated toward the left shoulder at a 25° 
angle, and rigidly fixated.
The surgeon was positioned on 
the patient’s right side. The abinostril 
approach start from the right nostril. 
A 0° rigid endoscope (180/4 mm) was 
used without an endoscope holder, 
although a 45° endoscope was also 
used occasionally. The endoscope was 
navigated into the nasal cavity until it 
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reaches the sphenoid floor (FIGURE 4A), 
which is approximately 1 cm above the 
inferior margin of the middle turbinate. 
A rescue flap to prevent injury to 
the vascular pedicle of the posterior 
nasoseptal artery was raised on the 
right side, and the middle turbinate was 
resected. A large opening was made 
both in the posterior nasal septum and 
anterior wall of the sphenoidal sinus by 
using a high-speed drill with a diamond 
burr. Inside the sphenoidal sinus, the 
sell turcica and optic carotid recess were 
identified, and the anterior wall and 
floor of the sella turcica were opened 
with a drill (FIGURE 4B and 4C). Once the 
dura mater was opened (FIGURE 4D), the 
tumor was removed (FIGURE 4E and 4F).
To reconstruct the sella turcica 
region, we used a combination of fascia 
lata, abdominal fat, and fibrin glue. A 
vascularized nasal septal flap, namely 
a mucoperichondrial flap based on the 
posterior nasoseptal artery, was raised 
as a final layer over the only graft, 
followed by a Foley catheter as a buttress 
to prevent significant intraoperative 
cerebrospinal fluid (CSF) leakage.
 
FIGURE 4. Endoscopic transsphenoidal procedure: A)Marking the area 
with a C-arm,B) drilling to open the sphenoid sinus,C) sella 
turcica,and D) dura mater, E) and F) identifying the tumor, 
followed by its removal.
F
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The patient was treated for 5 
days after surgery. The patient was 
admitted to the outpatient unit after her 
condition was stable and no significant 
postoperative complications were 
observed. One week after surgery, the 
patient reported less frequent headaches 
than before surgery and there was a 
gradual improvement in the limited 
vision of the right eye. The fingers and 
hands and feet were no longer enlarged, 
visible from the loose shoes.
The results of a histopathological 
examination indicated that the tumor 
consisted of sheet-shaped cells between 
erythrocytes. The cells were atypical, 
monomorphic, and solid, with either 
round or ovoid nuclei. Mitotic cells 
were not detected in the tumor, so the 
conclusion from the histopathological 
examination was a benign pituitary 
adenoma.
Ten weeks after surgery, a perimetric 
examination (FIGURE 5), CT scan of 
the head with contrast (FIGURE 6), 
and endocrinological evaluation were 
conducted. Among the results, the level 
of prolactin had normalized to 4.3 ng/mL 
(normal value: 2.8–29.2 ng/mL), while the 
level of growth hormone had dropped 
drastically to56.8 ng/mL (normal value: 
<8 ng/mL). It recommended for ongoing 
recurrence screening including annual 
CT scans and MRI monitoring.
FIGURE 5.  Results of a postsurgical perimetric examination: A) Nasal 
hemianopsia with improvement in the right eye and B) normal 
status in the left eye.
FIGURE 6. A CT scan of head with contrast shows no hyperdense lesions on the sella 
turcica and no hyper-or hypodense intracerebral lesions.
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DISCUSSION
The pituitary gland regulates the 
function of the thyroid gland, adrenal 
glands, ovaries, and testes, as well as 
controls lactation, uterine contractions 
during childbirth, linear growth, and 
the development and regulation of the 
osmolality and volume of intravascular 
fluid, namely by maintaining fluid 
absorption in the kidneys.8 The presence 
of a tumor in the pituitary gland disrupts 
hormone production, suppresses 
structures around the mass, and hinders 
blood supply to the gland.9,10 
In terms of hormonal function, 85 to 
90% of pituitary tumors are functioning 
tumors, whereas only 10 to 15% are non-
functioning.10–12 Functioning adenomas 
usually appear earlier than non-
functioning adenomas due to the effects 
of the hormones produced. By contrast, 
non-functioning adenomas, which are 
usually larger, exert a tumor- suppressive 
effect in the form of symptoms such as 
headaches, visual field defects, cranial 
nerve deficits, panhypopituitarism, and 
pituitary apoplexy.8,10,12
Patients with pituitary 
macroadenoma may be asymptomatic or 
else present with complaints caused by 
hormonal imbalance or tumor-inducing 
effects. Pituitary disorders have various 
clinical signs depending on the type, size, 
and progression of the tumors. Pituitary 
adenomas often indicate disorders 
caused by the hypo- or hyperfunction 
of the anterior pituitary hormones.4,13 
In our case, the patient presented with 
symptoms of acromegaly, including 
enlarged fingers and toes on both hands 
and feet, along with a widened and 
protruding forehead and jaw, enlarged 
nose and lips, prognathous jaw, and mild 
malocclusion for the past 4 years.
In general, hormonal effects depend 
on the type of hormone involved, 
especially according to the size and mass 
effect of the tumor and the hormonal 
abnormalities.12,14 The anterior pituitary 
cells are not as susceptible to tumor-
inducing effects as prolactin and 
somatotropin, whereas corticotrophin 
and thyrotropin are more resistant.4 In 
premenopausal women, possible clinical 
features include irregular menstruation 
and amenorrhea,4,8 as in our case, in 
which the patient had amenorrhea for 
4 years despite previously having a 
regular menstrual pattern every month. 
Amenorrhea in the patient occurred due 
to hyperprolactinemia, as evidenced 
by increased prolactin levels in the 
laboratory results. Hyperprolactinemia 
is a pituitary disorder that can cause 
amenorrhea, related to its effect on 
GnRH and estrogen deficiency.
Another clinical feature of 
macroadenoma relates primarily to the 
suppressive effect of the tumor on the 
surrounding structures, which in the 
sella turcica most often causes visual 
disturbances and headaches.10,14 In 
particular, impaired vision is caused 
by the compression of the optic nerve 
structures, due to which the lateral spread 
compresses the cavernous sinuses, 
thereby resulting in ophthalmoplegia, 
diplopia, and/or ptosis.4,10 In our case, 
the patient had a headache and a limited 
field of view in the right eye, which 
indicated that the tumor was in the sella 
turcica.
Such diagnoses are usually justified 
by the patient’s history and results 
of various physical examinations 
but nevertheless need confirmation 
by radiological and laboratory 
examinations. CT scans are quite specific 
and can detect tumors according to their 
calcification, whereas MRI can provide 
a clearer image of soft tissue structures 
and blood vessels. Beyond that, the high 
resolution allows MRI to recognize small 
lesions and can show their relationships 
with surrounding structures.1 In our 
case, a CT scan was performed with the 
results of a pituitary macroadenoma, 
which along with an MRI examination 
indicated a pituitary macroadenoma.
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Various studies have shown 
that 85 to 90% of all pituitary 
tumors are functioning tumors and 
mostly microadenoma.5,10,15imaging 
diagnosis, hormonal status, surgical, 
radiotherapeutic, and pharmacological 
treatment, and outcome. Results . 485 
patients (54% men, mean age 53 ± 14 
years Other research has indicated that 
most cases of pituitary macroadenoma 
involve non-functioning tumors, which 
cause clinical symptoms due to pressing 
the surrounding structures but do 
not increase hormonal activity.16 Our 
case showed the functioning pituitary 
macroadenoma was also characterized 
by increased levels of growth hormone 
and prolactin. Histopathological 
examination proved useful for 
categorizing tumor types, including in 
terms of aggressiveness, presence or 
absence of dura mater invasion, degree of 
granulation, and/or atypical appearance 
of cells.17 Histopathological examination 
results of our case ultimately confirmed 
a benign pituitary adenoma without any 
mitosis.
Managing a pituitary adenoma 
should prioritize decompressing the 
nervous system and restoring the 
normal secretion of hormones. To 
those ends, three basic therapeutic 
modalities that can be applied are 
operative therapy, radiation therapy, and 
therapy with drugs.6,7,10,18 In the past two 
decades, endoscopic transsphenoidal 
surgery has been widely used in the 
surgical management of pituitary 
adenomas. Zhou et al.6 reported on 1,166 
transsphenoidal endoscopic surgeries 
which reduced injury to the nasal cavity 
while executing the microsurgical 
approach and also provided better 
vision. The endoscopic transsphenoidal 
resection method of pituitary adenomas 
is more effective and safer than 
traditional microscopic approaches.6,7,18 
The endoscopic transsphenoidal 
approach provides panoramic vision 
within the surgical area, a better working 
angle, and minimal injury to the nasal 
cavity area.16
Reporting from Belgium, D’Haens 
et al.19 found that the incidence of 
complications (i.e., CSF leakage) 
for most patients after endoscopic 
transsphenoidal surgery was 10%.20 
Goudakos et al.21 demonstrated that rates 
of gross tumor removal and CSF leakage 
were similar between groups who 
received endoscopic versus microscopic 
transsphenoidal pituitary surgery. 
However, that same study revealed 
a lower incidence of postoperative 
diabetes insipidus and shorter hospital 
stays among patients in the endoscopic 
groups.21 Another systematic review by 
Razak et al.20 in the United Kingdom also 
observed the efficacy of transsphenoidal 
surgery and its capacity to reduce 
the need for craniotomy, even when 
the tumor volume appears large in 
preoperative imaging studies.
CONCLUSION
Functioning   pituitary   macroadenoma 
is a rare case of benign intracranial tumor, 
with symptoms that arise due to tumor 
pressing and increased hormone levels. 
Minimally invasive procedures such as 
endoscopic transsphenoidal surgery can 
assure minimal complications.
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